Metabolic Changes Associated With Metformin Potentiates BCL-2 Inhibitor, Venetoclax, and CDK9 Inhibitor, BAY1143572 and Reduces Viability of Lymphoma Cells

Oncotarget - United States
doi 10.18632/oncotarget.24989
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Metabolic Changes Associated With Metformin Potentiates Anti-BCL-2 Inhibitor, Abt-199, and Cdk9 Inhibitor, Bay-1143572 and Reduces Viability of Lymphoma Cells

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Loss in McL-1 Function Sensitizes Non-Hodgkin’s Lymphoma Cell Lines to the BCL-2-selective Inhibitor Venetoclax (ABT-199)

Blood Cancer Journal
OncologyHematology
2015English

GSK-3ß INHIBITOR, 9-Ing-41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B-Cell LYMPHOMA

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

The BCL2 Inhibitor Venetoclax Is Active in Non-Hodgkin Lymphoma

Cancer Discovery
Oncology
2017English

Overcoming the Radioresistance of Prostate Cancer Cells With a Novel BCL-2 Inhibitor

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2016English

Superior Anti-Tumor Activity of the MDM2 Antagonist Idasanutlin and the BCL-2 Inhibitor Venetoclax in P53 Wild-Type Acute Myeloid Leukemia Models

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

A CDK9 Inhibitor May Suppress Tumor Growth and Enhance Immunotherapy

Cancer Discovery
Oncology
2018English

Pan-BCL-2 Inhibitor Obatoclax Is a Potent Late Stage Autophagy Inhibitor in Colorectal Cancer Cells Independent of Canonical Autophagy Signaling

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy